Combipatch (estradiol/norethindrone Acetate Transdermal System) Patch, Extended Release
Product Images NDC 68968-0525

9 FDA label images from Noven Therapeutics, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Combipatch (estradiol/norethindrone Acetate Transdermal System) (NDC 68968-0525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Noven Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Combipatch Figure 1)

Chemical Structure (Combipatch Figure 1)
Chemical structures of the active ingredients estradiol and norethindrone acetate shown side-by-side. Estradiol's molecular structure is on the left, with labeled hydroxyl groups, while norethindrone acetate's steroid-based structure with an acetate group is on the right.*
FDA Label Image

Combipatch Figure 10

Combipatch Figure 10
Packaging label for CombiPatch 50/140 estradiol/norethindrone acetate transdermal system patch by Noven Therapeutics, LLC. The rectangular carton is blue with white and green accents, showing the proprietary name, strengths (50/140), and dosage form as an extended-release transdermal patch. The front panel displays the brand and generic names, dosing schedule (twice-weekly), and website. Additional instructions and barcode appear on side panels.*
FDA Label Image

Combipatch Figure 11

Combipatch Figure 11
Packaging label for CombiPatch 50/250 micrograms/25 micrograms per day estradiol/norethindrone acetate transdermal system patch. The label is predominantly green with blue and white text, showing the brand name CombiPatch and the dosage strength 50/250 prominently. It also includes instructions to read before applying the patch, storage temperature guidelines, and manufacturer information for Noven Therapeutics, LLC. The label directs users to open at a designated tab and includes barcodes and NDC 69896-0525-8.*
FDA Label Image

Layer (Combipatch Figure 2)

Layer (Combipatch Figure 2)
An instructional diagram illustrating the layers of a transdermal patch showing three distinct parts labeled Backing, Adhesive Layer, and Protective Liner. The image visually represents the patch's layered structure, relevant to transdermal drug delivery systems like CombiPatch (estradiol/norethindrone acetate transdermal system).*
FDA Label Image

Chart (Combipatch Figure 3)

Chart (Combipatch Figure 3)
A bar chart illustrating the percentage of women over 12 cycles using CombiPatch transdermal system at two different dosing regimens: 0.05/0.14 mg per day and 0.05/0.25 mg per day. The percentages increase with each cycle for both doses, with the higher dose generally showing a somewhat lower percentage compared to the lower dose.*
FDA Label Image

Figure A (Combipatch Figure 4)

Figure A (Combipatch Figure 4)
An instructional illustration showing hands peeling or removing a backing from a transdermal patch, labeled as Figure A. This figure visually demonstrates an initial step in applying a patch, likely related to CombiPatch (estradiol/norethindrone acetate transdermal system).*
FDA Label Image

Figure B (Combipatch Figure 5)

Figure B (Combipatch Figure 5)
An instructional illustration labeled "Figure B" showing two hands peeling off the backing from a transdermal patch, demonstrating part of the application process for CombiPatch (estradiol/norethindrone acetate transdermal system).*
FDA Label Image

Figure C,d (Combipatch Figure 6)

Figure C,d (Combipatch Figure 6)
Illustrative figures labeled C and D demonstrating the application of a CombiPatch estradiol/norethindrone acetate transdermal system. Figure C shows hands positioning the patch near the lower abdominal area, and Figure D shows a hand placing the patch on the skin of the abdomen, indicating the transdermal administration method.*
FDA Label Image

Figure E (Combipatch Figure 7)

Figure E (Combipatch Figure 7)
An instructional diagram showing the application of a CombiPatch estradiol/norethindrone acetate transdermal system patch to the skin on the lower abdomen, demonstrating placement using one hand.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.